Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06255912
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-23
First Post:
2023-12-26
Brief Title:
Clinical Trial for Advanced or Metastatic Pancreatic Cancer
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Study Overview
Official Title:
A Phase II Clinical Trial Assessing the Safety Tolerability and Pharmacokinetics of LTC004 in Combination With MIL-97 Chemotherapy in Patients With Advanced or Metastatic Pancreatic Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase II clinical trial assessing the safety tolerability and pharmacokinetics of LTC004 in combination with MIL-97 chemotherapy in patients with advanced or metastatic pancreatic cancer
This experiment is divided into two parts the dose increasing stage stage 1 and the dose expanding stage stage 2 For those enrolled in the planned expansion phase the dose should have passed the safety assessment during the dose escalation phase
This experiment is divided into two parts the dose increasing stage stage 1 and the dose expanding stage stage 2 For those enrolled in the planned expansion phase the dose should have passed the safety assessment during the dose escalation phase
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None